Pharmacare costing: How to make universal, single-payer pharmacare work for households and employers

  Yesterday’s announcement from the The Advisory Council on the Implementation of National Pharmacare, led by Dr. Eric Hoskins, was applauded by organizations and researchers across Canada who have long advocated for the introduction of a universal, single-payer pharmacare system. Journalists at the event, however, seemed to be focused on…
Read more

The New NAFTA is a missed opportunity for gender equality

The recent renegotiation of the North American Free Trade Agreement presented a unique opportunity to rethink the dominant model for governing international trade and investment. At the outset of the “New NAFTA” talks in August 2017, Foreign Affairs Minister Chrystia Freeland outlined the government’s priorities under the umbrella of a…
Read more

Why high U.S. drug prices matter to Canada

In the mid-1970s the average monthly cost of a cancer drug in the United States was about $100. By 1995 that cost had crept up to about $1,800 per month and today it is over $10,000. Similarly, while drugs for multiple sclerosis introduced in the mid-1990s cost about $8,000 per…
Read more

From fighting back to fighting forward: Strategizing across Canadian movements for jobs, justice, equality and the climate

In an increasingly chaotic world characterized by deep inequality and growing disillusionment with governments, public institutions and evidence, progressive movements offering a compelling and hopeful narrative for change have never been more important. Social justice, environmental sustainability and social solidarity are the keys to an inclusive, productive future for people…
Read more

Time to end the chill effect on Canadian charities

The Ontario Superior Court of Justice has confirmed that the Canada Revenue Agency’s (CRA) crackdown on charitable political activity has been an arbitrary and unjustified infringement upon freedom of expression. It’s time for the federal government to act swiftly to close the book on a dark time in Canada’s democratic…
Read more

The Ford government’s superficial arguments against pharmacare

Ontario’s new Progressive Conservative government is rejigging OHIP+, a modest but promising pharmacare policy introduced by the previous Liberal government, allegedly to make more efficient use of tax dollars. Where the short-lived program covered most prescription drug costs for people under 25, OHIP+ will now only cover people without individual…
Read more

Are middle class tax promises a false hope?

Ontario PC Leader Doug Ford has proposed a $2.8-billion “middle class tax cut,” despite the fact the province is facing a deficit. Promoting tax cuts as “middle class tax cuts” is the latest fad in election-time politics. Prime Minister Justin Trudeau promised to cut middle class taxes in the 2015…
Read more